Michael Aaron Rosenblum, PhD
TAPS Fellow
Research interests
Developing statistical tools to better detect causal effects of new HIV prevention methods in randomized trials; Estimating causal effects of antiretroviral adherence on viral suppression and resistance; Determining optimal antiretroviral dosing regimens
Current research
- HIV prevention clinical trials: Improved methods to estimate causal effects of interventions
- ARV therapy: analyzing relationships between adherence, viral suppression, and resistance
- New method for ensuring estimator consistency, under some types of model misspecification
Education
- 2007, TAPS Fellow, University of California, San Francisco
- 2005-2007, Postdoctoral Researcher, University of California, Berkeley
- 2004, PhD (Applied Mathematics), Massachusetts Institute of Technology
- 1999, Fulbright Grant for Probability Research, École Normale Supérieure, Paris, France
- 1998, MS (Mathematics), BS (Symbolic Systems), Stanford University
Publications/Papers
- Using
Regression Models to Analyze Randomized Trials: Asymptotically Valid
Hypothesis Tests Despite Incorrectly Specified Models, Michael
Rosenblum and Mark van der Laan
Slides from recent talk at Berkeley Statistics Colloquium on this work. - Analysis
of a New HIV Prevention Method (based on the MIRA clinicial trial
of latex diaphragms and gel), Michael Rosenblum, Nicholas P. Jewell,
Mark J. van der Laan, Stephen Shiboski, Ariane van der Straten, and
Nancy Padian
Slides from recent talk at Fred Hutchinson Cancer Research Center on this work. - Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial Nancy S Padian, Ariane van der Straten, Gita Ramjee, Tsungai Chipato, Guy de Bruyn, Kelly Blanchard, Stephen Shiboski, Elizabeth T Montgomery, Heidi Fancher, Helen Cheng, Michael Rosenblum, Mark van der Laan, Nicholas Jewell, James McIntyre, the MIRA Team. The Lancet - Vol. 370, Issue 9583, 21 July 2007, Pages 251-261
Contact
Michael Aaron Rosenblum, PhD
Center for AIDS Prevention Studies (CAPS)
University of California, San Francisco
50 Beale Street, Suite 1300
San Francisco, CA 94105
phone - 415/597-4965
e-mail - mrosenblum@ucsf.edu
Website
